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The purines, ATP and adenosine, are important signaling molecules in the nervous system. ATP is sequentially degraded to adenosine by the
ectonucleotidase proteins. The NTPDase (or CD39) family is a subfamily of these enzymes, which consists of nine members in mammals. In
Xenopus embryos, we have shown that ATP, and its antagonist adenosine, regulate the rundown of swimming and we therefore proposed that
ectonucleotidase proteins are key regulators of locomotor activity. Here, we report the cloning of all nine members of the NTPDase family in
Xenopus laevis and Xenopus tropicalis. Our phylogenetic analysis shows that this family is highly conserved between the frog species and also
during vertebrate evolution. In the adult frog, NTPDase genes are broadly expressed. During development, all NTPDase genes, except for
NTPDase8, are expressed and display a distinct specific expression pattern, suggesting potentially different functions of these proteins during
embryogenesis of X. laevis.
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Nucleotides are involved in many cellular and extracellular
processes such as cardiac function, muscle contraction and
relaxation, secretion of hormones, and cell growth (for review
see [1]). In the peripheral and central nervous systems, ATP
and adenosine are important neurotransmitter and modulator
molecules that have been implicated in the control of sleep [2],
regulation of pain pathways [3,4], and mediation of neuropro-
tection in the brain during transient ischemia [5]. In many
cases, adenosine is not directly released by neurons but is
produced from the breakdown of ATP by the ectonucleotidase
proteins [6]. These proteins therefore control both the
termination of ATP signaling and the accumulation of
adenosine. As both ATP and adenosine can act at several0888-7543/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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1 Joint PIs.distinct types of receptors, the ectonucleotidase proteins are a
key site of regulation for purinergic signaling.
In Xenopus embryos, these purines are important regulators
of spinal motor pattern generation. We have shown that ATP
and adenosine regulate the fatigue or run-down of swimming in
tadpoles. ATP, which is released from spinal neurons [7],
inhibits K+ currents and therefore increases excitability of the
locomotor network, whereas adenosine has the opposite effect
by inhibiting Ca2+ currents [8]. The production of adenosine can
be measured in spinal cord during locomotion [9,10]. Moreover,
we have proposed that the feed-forward inhibition by ADP of
the 5V-ectonucleotidase is a key determinant that delays the
generation of adenosine and thus regulates the rate of run-down
in Xenopus embryos [8,11]. By terminating the actions of ATP
and by initiating the effects of adenosine, members of the
ectonucleotidase families are therefore the major players in the
control of locomotor activity in frog embryos.
Nucleoside triphosphate diphosphohydrolases are members
of the ectonucleotidase superfamily. They are membrane-bound,
highly glycosylated proteins. Previously known as E-type
ATPases, ATPDases, ecto-ATPases, or ecto-apyrases, the mem-
bers of this family are now named NTPDases (or E-NTPDases)6) 366 – 381
www.el
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all hydrolyze nucleoside 5V-triphosphates and nucleoside 5V-di-
phosphates. Each member has specific substrate specificity and
subcellular localization. NTPDase genes have been cloned in
vertebrates, and homologues have also been identified in inver-
tebrates, plants, yeast, and protozoans. The family members
are characterized by the presence of five highly conserved
domains [apyrase conserved regions (ACR)], by their activity
dependence on divalent cations (Ca2+ and/or Mg2+), and their
insensitively to inhibitors of P-type, F-type, and V-type
ATPases.
In mammals, nine NTPDases have been identified thus far.
In adults, these genes display a broad tissue distribution with
overlapping expression domains. NTPDases 1 – 3 and
NTPDase8 are bound to the plasma membrane by two
transmembrane domains and their catalytic site is in the
extracellular milieu, classifying these proteins as ecto-
NTPDases. The other members (NTPDase4, NTPDases 5–7)
are endo-NTPDase proteins, bound either to the ER/Golgi or to
lysosomal membranes. However, NTPDases 5 and 6 have also
been found on the plasma membrane and can be secreted.
NTPDase1 was the first member cloned and was identified as
CD39 [12]. NTPDases 2 and 3 [13,14] and the recently cloned
NTPDase8 [15] are highly homologous to NTPDase1 but their
substrate specificity differs. NTPDase2 has a strong preference
for triphosphate nucleotides (ATP:ADP rate of hydrolysis of
¨30:1) [16], whereas NTPDases 1, 3, and 8 catalyze the
hydrolysis of triphospho- and diphosphonucleosides efficiently
with ATP:ADP rates of hydrolysis of ¨1:1, ¨3:1, and ¨2:1,
respectively [15–17]. Two splice variants of NTPDase4 have
been isolated, LALP70 and UDPase (LALP70v), and are now
referred as NTPDase4 and NTPDase4a [18–20]. They are
localized to the lysosomal/autophagic vacuole membranes and
to the Golgi, where they catalyze the hydrolysis of UTP and
UDP, respectively. LALP1 is now referred as NTPDase7 even
though its catalytic characteristic, protein sequence, and cellular
sublocalization suggest that this protein is more related to the
NTPDase4 proteins [21]. The last two proteins, NTPDases 5
and 6, are the only family members with one transmembrane
domain and they hydrolyze preferentially diphosphonucleo-
sides [22,23].
The role of the NTPDases is to regulate the concentration of
extracellular and intracellular nucleotides and therefore they are
involved in many functions mediated by NTPs. However,
specific functions have been ascribed to some of these proteins.
The knock-out mouse for NTPDase1 identified a role for this
protein in hemostasis, thromboregulation, and angiogenesis
[24,25] and also in the modulation of inflammation and
immune responses mediated by extracellular nucleotides [26].
These studies are the first to identify the functional role of a
member of this family in vivo in a vertebrate. However, in
vitro, NTPDase2 has been shown to promote platelet aggrega-
tion, an opposite role to the NTPDase1 function [27]. Finally,
the identification of NTPDase5 as the PCPH proto-oncogene
links the NTPDase family to carcinogenesis [28]. The functions
of these nine NTPDases are likely to be numerous and,
therefore, still need to be elucidated in vivo.X. laevis provides a very powerful model organism for the
establishment of gene function. Misexpression of genes can be
achieved by microinjection of the mRNA of interest and
knock-down models can now be obtained by using morpho-
linos ([29] or for review see [30]). This, coupled with the
availability of physiological methodologies and computational
models [11] by which to test the roles of these enzyme families
in physiological processes, makes Xenopus an ideal organism
in which to study this important gene family.
Here, we report the cloning and characterization of nine
members of the NTPDase family in X. laevis, the first and
necessary step before analyzing their functions in vivo. We also
present and compare their temporal and spatial expression
patterns in frog embryos and then their distribution in adult
tissues. We have also identified the members of this family in
Xenopus tropicalis and conducted a phylogenetic analysis of
these genes in both of these two Xenopus species. This work is
the first study that describes the complete embryonic expres-
sion pattern of all the members of this family during the
development of a vertebrate model organism.
Results
Cloning of Xenopus NTPDase genes
To clone the NTPDase family of genes in Xenopus laevis and
X. tropicalis, we opted to search the NCBI Internet site and JGI
Internet site to identify EST clones. Where no ESTs were
available, we searched the X. tropicalis genomic database on the
JGI website. A combination of approaches was used, detailed
below for each gene. All the positive EST clones (Table 1) were
ordered from the UK MRC HGMP Resource Centre, Cam-
bridge, and checked by sequencing. Further rounds of sequenc-
ing were carried out to obtain the full-length sequences.
Isolation and sequence characterization of Xenopus
NTPDase1 gene
Interrogation of the Unigene database on the NCBI internet
site identified the clone CF282534 (now BC073267), as being
2933 bp long. The open reading frame encodes a protein of 508
aa, with a calculated molecular weight of 57,012 kDa. The
ATG at nucleotide position 24 was identified by homology
with the human and mouse NTPDase1 sequences, since the
sequence of the translation initiation GAACTGAUGG showed
a weak homology to the consensus Kozak sequence [31]. The
deduced amino acid sequence of X. laevis NTDase1 (Acces-
sion No. AAH73267) is shown in Fig. 1. The five apyrase
conserved domains, characteristic of the NTPDase family, are
present. Prediction of transmembrane helices using the TM-
Base software allowed the identification of two transmembrane
domains, one at the N-terminal region (aa positions 17 to 38)
and the other at the C-terminal region of the protein (aa
positions 477 to 495).
X. tropicalis NTPDase1 protein sequence is available on the
NCBI Internet site under Accession No. AAH76662. This
protein is 508 aa long with a calculated molecular weight of
Table 1
Accession number of the different clones used to clone the Xenopus laevis and tropicalis NTPDases and their final Accession numbers
Marker X. Laevis X. tropicalis
EST used: GenBank
Accession No.
Clone I.M.A.G.E.
ordered: ID
DNA and (protein):
GenBank Accession No.
EST JGI and GenBank
Accession No.
DNA and (protein)
GenBank Accession No.
Scaffold JGI site
NTPDase1 CF282534 5506434 BC073267 (AAH73267) NA BC076662 (AAH76662) 194
NTPDase2 BC041316 4724933 BC041316 NA BC068034 (AAH68034) 3857
NTPDase3 BM192699 4959899 DQ117605 CAAK5700 NA
CAAK5075
CAAL8293
NTPDase4 CA987811 6643553 BC084934 (AAH84934) CAAM5959 DQ118413 763
XZG14195
XZG60394
XZG22008
NTPDase5 None None DQ117607 DN054228 DQ118410 423
CX414575
NTPDase6 CA986853 6863373 DQ117604 CABI9753 DQ118411 911
CAAM4216
NTPDase7 BG363994 3402672 DQ117608 CAAR11804 DQ118412 194
CA987676 6864377 CABK7953
CABD9008
NTPDase8 None None DQ117606 None DQ118409 302
Note. EST clones were identified by TBLASTN performed on the NCBI or JGI Internet sites. Scaffolds containing the genomic sequence of X. tropicalis NTPDase
genes were identified by TBLASTN performed on the JGI site. X. laevis EST clones were ordered from the UK MRC HGMP Resource Centre, Cambridge.
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to its X. laevis homologue (89.3% identity, cf. Table 2), the five
apyrase conserved domains and the two transmembrane
domains are present and their positions are conserved between
the two frog species.
Isolation and sequence characterization of Xenopus
NTPDase2 gene
Searching the Unigene database for NTPDase2-related
sequences identified clone BC041316 (Table 1). This clone,
2500 bp long, contained an open reading frame of 1503 bp
encoding a protein of 500 amino acids with a calculated
molecular weight of 55,595 kDa. The translation initiation site
was identified at nucleotide position 19, based on the
homology of sequence compared to the consensus sequence
(CCCAACAUGG versus consensus GCCA/GCCAUGG) [31].
A single polyadenylation signal of AAUAAA was found at
nucleotide position 2448, 15 bases 5V of the poly(A) tail of
clone BC041316. The deduced amino acid sequence is shown
in Fig. 1. Sequence analysis predicted two transmembrane
domains, one at the N-terminal domain of the protein (aa
positions 5 to 24) and the other at the C-terminal domain (aa
positions 471 to 487). The predicted protein contains the five
apyrase conserved domains (Fig. 1).
X. tropicalis NTPDase2 protein (Accession No. AAH68034)
was identified by TBLASTN analysis with the X. laevis
sequence (Table 1). The protein is 500 aa long with a calculatedFig. 1. Alignment of Xenopus NTPDase proteins. The 16 sequences of the X. laevi
CLUSTALW [45] on the Infobiogen Internet Site. Residues conserved either in all se
background. Residues conserved in the group of NTPDases 1, 2, 3, and 8 sequences ar
sequences are indicated by a green background. Residues conserved in NTDase4 an
sequences are indicated by a dash. The five apyrase conserved regions are highlight
underlined. D, NTPDase.molecular weight of 55,269 kDa. Like NTPDase1 proteins,
NTPDase2 proteins are highly conserved between the two frog
species (85.6% identity). X. tropicalis NTPDase2 contains the
five apyrase conserved domains (Fig. 1). Sequence analysis
predicted two transmembrane domains, located at the same
positions as those in the X. laevis protein.
Isolation and sequence characterization of Xenopus
NTPDase3 gene
EST clone BM192699 was identified by a TBLASTN search
on the EST_others database with the homologous human
NTPDase3 protein sequence. Sequencing of BM192699, which
is 2606 bp long (DQ117605), identified an open reading
frame (ORF) of 1500 bp, encoding a protein of 499 aa with
a calculated molecular weight of 56,294 kDa. The ORF is
defined by the ATG at nucleotide position 98, by homology
with the mammal homologues. A single polyadenylation
signal of AAUAAA was found at nucleotide 2570, 11 bases
upstream the poly(A) tail. The deduced amino acid sequence
of X. laevis NTPDase3 is shown in Fig. 1. As expected, the
protein contains the five apyrase conserved domains and two
transmembrane domains, at the N-terminal and C-terminal
regions of the protein (aa position 7 to 29 and 476 to 494,
respectively).
EST clones coding for X. tropicalis NTPDase3 were
identified by a TBLASTN performed on the JGI Internet site
with the X. laevis NTPDase3 protein sequence. Alignment ofs(Xl) and X. tropicalis (Xt) NTPDase proteins were aligned using the software
quences or in at least two of the three groups of proteins are indicated by a black
e indicated by a dark blue background. Residues conserved in NTPDases 5 and 6
d NTPDase7 sequences are indicated by a light blue background. Spaces in the
ed by the red boxes. The sequences of the putative transmembrane domains are
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CAAL8293 allowed us to generate the consensus sequence
of this gene. As shown in Fig. 1, the last 11 amino acids aremissing from the deduced X. tropicalis NTPDase3 protein
sequence. This protein is highly identical to its X. laevis
homologue (87.8% identity, Table 2) and displays the
Table 2
Relatedness between the X. laevis (Xl) and X. tropicalis (Xt) NTPDase (D) proteins and their human (H) homologues
XlD1 XtD1 HD1 XlD2 XtD2 HD2 XlD3 XtD3 HD3 X1D4 XtD4 HD4 XlD7 XtD7 HD7 XtD5 HD5 X1D6 XtD6 HD6 XtD8 HD8
XlNTPDase1 100
XtNTPDase1 89.8 100
HNTPDase1 54.4 56 100
XlNTPDase2 41.3 40.8 39.3 100
XtNTPDase2 41 41.2 39.2 85.6 100
HNTPDase2 39.3 39.2 37.7 56.0 55.2 100
XlNTPDase3 41.6 40.8 39.1 40.5 41.1 39.7 100
XtNTPDase3 40.8 40.5 40 39.2 39.9 39.3 87.8 100
HNTPDase3 41.2 41.1 37.4 40.7 40.2 38.1 59.5 57.8 100
XlNTPDase4 23.6 23.1 23.9 23.9 23.9 26.6 24.2 25.7 23.5 100
XtNTPDase4 23.3 23.1 23.2 24.6 24.4 26.2 24.3 25.7 23.3 94.7 100
HNTPDase4 23.7 25.1 25.7 24.3 23.7 26.5 25.6 25.6 25.3 77.1 76.6 100
XlNTPDase7 22.6 22 24.1 25.4 23.7 24.1 23.8 22.6 23.1 59.3 59.2 60.6 100
XtNTPDase7 22.6 23 25.4 25.8 23.8 25.6 24.7 24 23.7 60.2 59.9 61.3 90.6 100
HNTPDase7 23.4 23 25.1 25.9 24.6 27.3 23.8 24.6 23.4 60.2 59.4 61.6 68.1 68 100
XtNTPDase5 22.7 22.1 24.2 23.3 23.3 24.6 23.2 25 21.7 21.9 22 22.4 21.6 21.7 22.7 100
HNTPDase5 25.5 24.5 25.8 23.2 22.7 26 24.9 26.5 24 21 21.2 22 22.3 22.7 23.2 49.5 100
XlNTPDase6 26.6 26.1 24.6 24.1 24.8 23.6 23.8 23.7 24.1 22.8 22.4 21.8 21.6 21.7 22.6 40.3 43.3 100
XtNTPDase6 26.2 25.8 24.8 24.8 23.7 23.7 24.2 25.1 22.8 22.5 21.7 22.2 23 23.1 22.7 41.9 46.4 87.8 100
HNTPDase6 22.2 22.6 23.6 22.2 21.7 24.4 23.5 23 22.4 22 21.7 22.3 22.7 23.4 22.9 38.7 44.9 52.7 52.9 100
XtNTPDase8 35.7 35.8 37.1 36.3 35.4 38.4 35 37.9 34.8 19.4 19.9 20.5 18.7 19.8 20.3 22.3 26 23.5 23 19.2 100
HNTPDase8 39 38.8 40.2 38.7 38.9 41.2 38 36.9 36.5 24.8 23.9 23.8 23.3 22.7 23 24.3 27.2 24.5 25.6 22.7 47.9 100
Note. The percentage of amino acid identity between these proteins was determined by pairwise alignment using ALIGNp software on the Infobiogen Internet site.
The GenBank accession numbers are given in the legend to Fig. 2. As the X. tropicalis NTPDase8 sequence is incomplete, the alignment was performed with
sequences starting after the ACR2 domain.
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domains and five apyrase conserved domains.
Isolation and sequence characterization of the two Xenopus
NTPDase4 genes, NTPPase4 and NTPDase4a
In mammals, two highly identical NTPDase4 proteins have
been identified: NTPDase4 (LALP70) and NTPDase4a
(UDPase) [18,19]. A TBLASTN search with the human
NTPDase4 protein sequence allowed us to identify EST clones
for X. laevis NTPDase4 genes. Sequence analysis identified the
protein encoded by the CA987811 clone as X. laevis NTPD-
ase4 since this protein is 77.1% identical to human NTPDase4
and only 75.9% identical to human NTPDase4a and displays
the additional 8 amino acids VSFASSQQ (position 287–294)
that are characteristic of NTPDase4 proteins and absent from
the NTPDase4a proteins. The CA987811 clone is 3.7 kb long;
its ORF encodes a protein of 616 aa, with a calculated
molecular weight of 70,567 Da. The five apyrase domains are
present and two transmembrane domains have been identified,
one in the N-terminal region (aa 34 to 53) and one in the C-
terminal region (aa 565 to 583). The X. laevis NTPDase4
protein is now available in the databases under Accession No.
AAH84934.
TBLASTN performed on the JGI Internet site allowed the
identification of several ESTs for X. tropicalis NTPDase4.
Alignment of CAAM5959, XZG14195, XZG60394, and
XZG22008 clones’ sequences generated the consensus se-
quence of this protein. However, the N-terminus of the
protein sequence (151 aa) was missing. We therefore
performed the same search on the genomic database andidentified scaffold 763 as containing this sequence. By
comparison to the X. laevis sequence and according to the
Breathnach and Chambon law [32], the complete protein
sequence, except for the 2 first amino acids, encoded by this
gene was deduced and compared to that obtained by the EST
search. The final sequence is shown in Fig. 1 and shows
94.7% identity with the X. laevis sequence (Table 2). X.
tropicalis NTPDase4 (Accession No. DQ118413) is 617 aa
long. The five apyrase conserved domains are present, as are
the two putative transmembrane domains.
Human NTPDase4a has been shown to be the splice variant
of the human NTPDase4 gene [20]. By analysis of the X.
tropicalis NTPDase4 genomic sequence and comparison to its
human homologue, a putative alternative splice site has been
identified, as shown in Fig. 2A. This alternative donor site is
localized at the end of exon 6 on scaffold 763. The N-terminus
(2 first amino acids) of the X. tropicalis NTPDase4 protein is
absent from the identified region of scaffold 763. In human, the
first intron is located 8 bases after the ATG, only coding for the
2 first amino acids [20]. We predicted that it was the same in X.
tropicalis, suggesting that the first exon of the X. tropicalis
NTPDase4 gene was not identified during our search.
Therefore, we conclude that the position of this alternative
splice site is identical to that in the human gene, located at the
end of exon 7. Due the high degree of conservation between
the two species of Xenopus, we speculated that this alternative
splice site would exist in the X. laevis genome, leading to the
potential existence of X. laevis NTPDase4 and NTPDase4a
proteins. To check this hypothesis, primers were designed (Fig.
2B) to specifically identify the two splice variants and RT-PCR
was performed at different stages during X. laevis development
Fig. 2. Characterization of the two splice variants, NTPDase4 and NTPDase4a. (A) Part of the genomic sequence of scaffold 763 illustrating the alternative splice
sites (in boldface type) used to generate either the NTPDase4 or the NTPDase4a transcripts. (B) Alignment of the sequences of X. laevis NTPDase4 and
NTPDase4a. RT-PCR was performed on adult brain tissue and the products were cloned into pGEMT-easy and sequenced. The sequences of the primers used in this
study are indicated in gray. (C) RT-PCR analysis showing the temporal expression of NTPDase4 and NTPDase4a during X. laevis development. NTPDase4 is more
highly expressed than NTPDase4a at all stages tested. The 133-bp fragment represents NTPDase4; the 109-bp band represents NTPDase4a. (D) RT-PCR analysis
showing the spatial expression of these two genes in the adult frog. NTPDase4 (133-bp fragment) is more highly expressed than NTPDase4a (109-bp fragment) but
their relative expression differs depending on the tissue analyzed.
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transcripts were amplified and after sequencing identified as
NTPDase4 and NTPDase4a genes (Fig. 2B), since the
mammalian NTPDase4 is 8 amino acids (VSFASSQQ) longer
than NTPDase4a. During development, both genes are
expressed at all stages tested; however, the NTPDase4 gene
is more highly represented than its splice variant. In the adult,
both variants are ubiquitously expressed. However, different
relative expression in different tissues such as spinal cord and
kidney is observed. NTPDase4 is more highly represented than
NTPDase4a, which has an almost undetectable expression in
the lung, pancreas, testis, and muscle.
Isolation and sequence characterization of Xenopus
NTPDase5 gene
Positive ESTs could only be identified in X. tropicalis (cf.
Table 1), but the 3V end of the gene is missing from these
clones. Therefore, a TBLASTN search was performed on the
genomic X. tropicalis database and scaffold 423 was identified
as containing these sequences. The cDNA sequence for this
gene was corrected by reference to the mammalian homologues
and according to the Breathnach and Chambon law [32].
Fragment 593802–605090 corresponds to the genomic coding
region of NTPDase5. The first 9 amino acids were missingfrom this sequence but were present in the EST clone.
Compared to the human sequence, the last 3 amino acids were
also not identified in our search. As shown in Fig. 1, X.
tropicalis NTPDase5 (Accession No. DQ118410) is 424 aa
long, with a calculated molecular weight of 47,454 kDa. As
expected by comparison to its human homologue, only a single
transmembrane domain can be identified (7–24 aa) and the
five apyrase conserved domains characteristic of the NTPDase
family are present.
Primers were chosen from the X. tropicalis sequence in a
region highly identical to the human sequence and RT-PCR
was performed on a range of embryonic stages and adult
tissues. An amplification product of 481 bp was sequenced and
identified as X. laevis NTPDase5 (DQ117607) by homology to
the X. tropicalis sequence, indicating that although EST
sequences were not present in the databases, this transcript is
found in X. laevis.
Isolation and sequence characterization of Xenopus
NTPDase6 gene
The EST clone (CA986853) for X. laevis NTPDase6 was
identified by a TBLASTN search with the homologous human
sequence. The ORF, 1407 bp long, encodes a protein of 468 aa,
with a calculated molecular weight of 52,021 kDa. The
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human homologue at nucleotide position 186; only one
polydenylation site was found, 29 bases upstream of the poly(A)
tail of this clone. The deduced amino acid sequence of X. laevis
NTPDase6 (DQ117604) is shown in Fig. 1. As with the other
NTPDase proteins, the five conserved apyrase domains are
present. Moreover, only one putative transmembrane domain
could be identified, in the N-terminal region of the protein, at
position aa 35 to 55, as expected by homology to its mammal
homologues [14].
X. tropicalis NTPDase6 sequence was deduced from an
alignment of the sequence of the EST clones (CABI9753 and
CAAM4216) and of the genomic fragment bp 156075–179230
of scaffold 911. X. tropicalis NTPDase6 (Accession No.
DQ118411) is 467 aa long, highly identical to X. laevis
NTPDase6 (87.8% identity, Table 2). Only a single transmem-
brane domain can be identified at the same amino acid position
as in X. laevis NTPDase6. The five apyrase conserved domains
are also present.
Isolation and sequence characterization of Xenopus
NTPDase7 gene
EST CA987676 and BG363994 clones for X. laevis
NTPDAse7 were identified by a TBLASTN performed on
the NCBI site with the human NTPDase4 sequence.
The predicted proteins encoded by these clones are identical
and are more similar to the NTPDase7 proteins than to the
NTPDase4 proteins. However, the 3V-UTR sequences of these
two clones are different, suggesting the possibility of different
transcripts or that they represent the two alleles of theNTPDase7
gene. However, neither of these clones contains the 5V end of the
gene and attempts to identify more 5V EST clones failed.
However, a similar search allowed us to identify ESTs
clones (CAAR11804; CABK7953; CABD9008) and the
genomic fragment 1703997–1718004 of scaffold 194 coding
for the X. tropicalis NTPDase7. Alignment of these sequences
allowed the generation of the consensus sequence of this
protein (Accession No. DQ118412), shown in Fig. 1. Only the
first 2 amino acids are missing from this sequence, allowing us
to design primers based on this sequence to amplify the 5V end
of the X. laevis NTPDase7 gene. A 1137-bp product was
therefore sequenced and 276 aa of the N-terminus of the X.
laevis protein were identified. The first 8 amino acids, by
reference to its human homologue, are missing from this final
sequence (Accession No. DQ117608).
As shown in Fig. 1, the two proteins are highly identical
(90.6% identity, Table 2). The five apyrase domains are conserved
in the two protein sequences, and two putative transmembrane
domains can be identified in the N- and C- termini of these
proteins (aa 21–39 and 551–569 for X. laevis NTPDase7).
Isolation and sequence characterization of Xenopus
NTPDase8 gene
No ESTs coding for X. laevis and tropicalis NTPDase8 were
identified. However, scaffold 302 was identified as containingX. tropicalis NTPDase8 sequences during a TBLASTN search
with the human NTPDase8 sequence. As described above, the
X. tropicalis cDNA sequence was corrected and the protein
sequence deduced (Accession No. DQ118409). The sequencing
of this scaffold is still in progress, as shown in Fig. 1, and so
the NTPDase8 sequence is incomplete. The sequences between
amino acids 83 and 135 and between amino acids 354 and 366
(with reference to the human sequence) and the C-terminus of
the protein are missing. However, X. tropicalis NPTDase8
displays the apyrase conserved domains (except ACRII, whose
sequence is currently unavailable from the database).
Since no X. laevis sequences were available, primers were
designed on X. tropicalis sequence in regions highly similar to
the mammalian homologues and RT-PCR was performed on
embryonic stages but also in adult tissues. NTPDase8 was
found to be expressed in some adult tissues of X. laevis;
however, no amplification was obtained at any embryonic stage
tested. The amplification product of 159 bp was sequenced and
identified as X. laevis NTPDase8 (DQ117606) by homology to
the X. tropicalis sequence.
Phylogenetic analysis of the NTPDase family
As shown in Fig. 1, the Xenopus NTPDase proteins have a
high percentage of identity over the five apyrase conserved
regions. The core regions of the apyrase domains, represented
by black boxes in Fig. 1, are almost completely conserved in all
sequences analyzed. However, the overall percentage of
identity among members of the X. laevis family of proteins
is only 22.6 to 59.3% (Table 2). The same observation can be
made for X. tropicalis sequences, in which the highest
percentage of identity is 59.9% between NTPDase4 and
NTPDase7 sequences. As shown in Fig. 1, the N- and C-
terminal regions of each member of this family are highly
conserved between the two frog species but these regions are
different in each family member, suggesting a specific function
for these protein domains. However, these domains are highly
identical between the NTPDase4 and NTPDase7 proteins,
showing the strong conservation of these proteins.
Analysis of the amino acid conservation between the family
of Xenopus proteins and their mammalian homologues showed
a higher level of identity among species for a specific NTPDase
family member than among different NTPDase family mem-
bers within the same species. For example, X. laevis
NTPDase1 shares 89.8 and 54.4% identity with X. tropicalis
and human NTPDase1 proteins, respectively, and only 41.3 or
41.6% identity with X. laevis NTPDase2 or NTPDase3,
respectively (Table 2).
The phylogenetic tree illustrates clearly the relatedness of
the NTPDase proteins (Fig. 3). In every case, each member of
the family is more related to its homologues in other species
than to the other family members in the same species. The
existence of three major subgroups in the NTPDase family is
suggested by this analysis, with NTPDases 1, 2, 3, and
8 belonging to the first group, the NTPDase4 and NTPDase7
proteins belonging to the second group, and finally NTPDases
5 and 6 belonging to the third group.
Fig. 3. Phylogenetic tree of vertebrate NTPDase proteins. A phylogenetic tree was constructed with the software AliBee [48] on the Genebee Internet site. A cluster
algorithm was used to build the tree. Bootstrap values are indicated at each node of the tree. The GenBank accession numbers of NTPDase proteins are as follows:
human NTPDase1: NP_001767; human NTPDase2: NP_001237; human NTPDase3: NP_001239; human LALP70 (NTPDase4): Q9Y227; human NTPDase5:
NP_001240; human NTPDase6: NP_001238; human NTPDase7: NP_065087; human NTPDase8: AAQ89446; mouse NTPDase1: P55772; mouse NTPDase2:
NP_033979; mouse NTPDase3: NP_848791; mouse NTPDAse4(LALP70): Q9DBT4; mouse NTPDase5: NP_031673; mouse NTPDase7: AAG01009; mouse
NTPDase8: AY364442; rat NTPDase1: P97687; rat NTPDase2: O35795; rat NTPDase3: CAD24724; rat NTPDase5: NP_955426; rat NTPDase6: NP_445950; rat
NTPDase7: XP_239062; rat NTPDase8: XP_231041. H, human; M, mouse; R, rat; Xl, X. laevis; Xt, X. tropicalis.
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frog
The spatial expression of these NTPDase genes in the adult
frog was analyzed by RT-PCR. As shown in Fig. 4, these genes
display different expression patterns.Fig. 4. Spatial expression profile of NTPDase family genes in the adult frog. RT-PCR
genes show different expression patterns. NTPDase1, 4, 6, 7, and 8 were expressed i
specific, with the highest level of expression in the nervous system. NTPDase5 is the
a loading control. The linearity was performed with doubling dilutions of cDNA from
NTPDase7; kidney for NTPDase5; spinal cord for NTPDase6; and ileum for NTPNTPDase1, NTPDase4, NTPDase7, and NTPDase8 appear
to be expressed in a wide range of organs in the adult frog;
however, the level of expression for each of these genes is
higher in some organs. NTPDase6 expression can be detected
at a low level in all tissues tested, suggesting a ubiquitous
function of this protein in the adult frog. The level ofwas performed with total RNA extracted from X. laevis adult tissues. NTPDase
n almost all tissues studied, whereas the expression of NTPDase2 and 3 is more
only gene of the family not expressed in the nervous system. EF1a was used as
the following tissues: brain for NTPDase1, 2, and 3; ovary for NTPDase4 and
Dase8.
Fig. 5. Temporal expression profile of NTPDase family genes. RT-PCR analysis showing the expression pattern of NTPDase transcripts in X. laevis unfertilized eggs
and embryos. Expression of NTPDase1, 2, and 3 is up-regulated at stage 19 and remains at approximately the same level until stage 45, the latest stage tested.
Expression of the NTPDase7 gene is constant during development, whereas NTPDase8 is not expressed at any stage tested. NTPDase4 and NTPDase6 are maternal
genes; their zygotic expression is switched on at stage 19 and they remain expressed until stage 45. Expression of NTPDase5 is first detected at stage 33. ODC was
used as a loading control. The linearity was performed with doubling dilutions of cDNA from stage 45 embryos except for NTPDase1 and NTPDase7; cDNAs from
stage 27 and 12.5 were used, respectively.
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duodenum, and ileum. NTPDase8 is more expressed in the
pancreas, ileum, and lung. The NTPDase4 and NTPDase1
genes appear to be weakly expressed in the adult. NTPDase4
shows a higher level of expression in brain, spinal cord, kidney,
duodenum, and ovary, and NTPDase1 is expressed at higher
levels in ovary, brain, eye, spleen, ovary, and muscle.
NTPDase2, NTPDase3, and NTPDase5 display a more
restricted expression pattern. NTPDase2 has significant ex-
pression in brain, spinal cord, and heart. The NTPDase3 and
NTPDase5 genes are the most tissue specific. The level of
expression of NTPDase3 is very high in the nervous system
and in the eyes, the only sensory organ tested in this
experiment. The NTPDase5 gene is expressed highly in the
kidney and pancreas. Interestingly, NTPDase5 is the only gene
of the family not to be expressed in the nervous system.
Temporal expression of the NTPDase gene family during
development of X. laevis
The temporal expression of these genes during development
was assessed by RT-PCR (Fig. 5). The NTPDase genes can be
grouped according to their expression patterns during devel-Fig. 6. Spatial expression profile of NTPDase1, 2. and 3 during development. (A) W
probe was performed on embryos from stages 19–41. Stained embryos were photog
stage 19 in the notochord, when embryos were cleared (iv). At stage 26, the staining is
somites (i, v). At stage 34,NTPDase1 remains expressed in the notochord but only in t
and lateral blood islands and in the eyes (ii, vi). At later stages,NTPDase1 is still expre
situ hybridization with anNTPDase2 DIG-labeled antisenseRNAprobewas performe
iii) and after being cleared (iv–vi). NTPDase2 is expressed from stage 19 in the somit
At stage 39, the staining is still strong in the somites; however, weak expression can be
(I, v). The sense probe showed no staining (iii). (C). Whole-mount in situ hybridiz
embryos from stages 19–41. Stained embryos were photographed before (i, iv) and af
the spinal cord (i). The staining in more obvious on cleared embryos (ii). Detail of the s
the spinal chord (iii). At later stages, NTPDase3 is still expressed in the spinal chord
Dorsal view of a stage 39 embryo’s head shows that NTPDase3 is expressed in the trig
The differences in colors result from clearing the embryos and photographing them a
forebrain; h, heart; n, notochord; s, somites; sp, spinal cord; tgg, trigeminal ganglia;opment of X. laevis. First, NTPDase1, 2, and 3 are not
expressed maternally and their zygotic expression is clearly
visible at stage 19. With additional PCR cycles, zygotic
NTPDase2 expression can be detected weakly during gastru-
lation. NTPDase1, 2, and 3 remain expressed at a similar level
until stage 45, the last stage tested in this experiment.
NTPDase5 is also not expressed maternally, and so falls into
this group, but in contrast to these last three genes, its zygotic
expression is first detected at swimming tadpole stages. The
second group is composed of NTPDase4 and NTPDase6,
which are expressed maternally. Their zygotic expression is
detected at late neurula stages and is comparable to the last
group of genes. However, it seems that the expression of
NTPDase4 decreases during stages 25 to 41, whereas the level
of expression of NTPDase6 increases slowly until stage 41.
The NTPDase7 gene belongs to the last group. Its expression
was seen at all stages tested, with an increase in expression at
stage 19. No expression at any embryonic stage tested could be
detected for NTPDase8, even though amplification of this gene
can be achieved in the adult frog (Fig. 4). Although these genes
display different expression patterns, the zygotic expression of
five of these genes increases during late neurulation, suggesting
a possible role for these proteins in neural differentiation.hole-mount in situ hybridization with an NTPDase1 DIG-labeled antisense RNA
raphed before (i – iii) and after being cleared (iv–vi). Expression was detected at
very strong in the notochord and can also be seen in the cement gland and in the
he tailbud of the embryo. However, new expression can be detected in the ventral
ssed strongly in the eyes and in the ventral blood island (iii). (B)Whole-mount in
d on embryos from stages 19–41. Stained embryoswere photographed before (i–
es (iv). At stage 27, expression can be detected only in the developing somites (i).
detected in the head of the embryos (ii), tissues totally unstained at previous stages
ation with an NTPDase3 DIG-labeled antisense RNA probe was performed on
ter being cleared (ii, iii, v, vi).NTPDase3 expression is first detected at stage 34 in
tained embryo shows thatNTPDase3 expression is restricted to the dorsal root of
(iv) but some patches of staining can be detected in the head of the embryo (v).
eminal ganglia (vi). All embryos were analyzed from the same experimental set.
gainst a white background to visualize staining. dlp, dorsal lateral plate; e, eye; f,
vbi, ventral blood island.
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development of X. laevis
The spatial expression of these genes in the embryo was
assessed by two different complementary techniques. In situ
hybridization allows the identification of domains of high
expression of genes; RT-PCR, on the other hand, identifies
regions of both high- and low-expression domains in dissected
embryos.In situ hybridization was performed on embryos from stage
19 to stage 41 with 3V-UTR-specific antisense probes; sense
probes were used as controls. As shown in Figs. 6 and 7,
NTPDase genes display distinct, and different, expression
domains during X. laevis development.
NTPDase1 is first detected at late neurula stages. At stage 19
and during early tailbud stages, NTPDase1 is highly expressed
in the notochord as shown clearly in Fig. 6A, iv–v, after clearing
the embryos. At later stages, the expression in the notochord is
K. Masse´ et al. / Genomics 87 (2006) 366–381376maintained only in the tailbud of the embryo (Fig. 6A, ii and iii).
NTPDase1 is also expressed in the developing somites (Fig. 6A,
i–iii). Strong expression is also detected in the sensory organs
especially in the eye at stage 34 (Figs. 6A, ii and vi). Staining is
also found in the ventral blood island and in the dorsal lateral
plate, the two blood compartments, at tadpole stages. This blood
island expression is unique to this member of this gene family.
NTPDase2 is strongly expressed in the somites from stage
19 (Fig. 6.B, iv) to stage 39 (Fig. 6.B, ii, v, and vi). No staining
was seen with the control sense probe (Fig. 6. B, iii). No
expression can be detected in the head of early embryo (Fig.
6B, v), but at late tadpole stages, staining in the forebrain can
be detected (Fig. 6B, ii). Staining in the heart is also seen at
these late stages.
NTPDase3 displays a very specific tissue expression
domain. No expression can be detected before stage 34. Fromstage 34 to stage 41, expression in the spinal cord is detected
(Fig. 6C, i and iv) especially after clearing the embryo (Fig. 6C,
ii and v). As shown in the detail of a stage 34 embryo (Fig. 6C,
iii), expression is seen only in the dorsal part of the spinal cord.
Sectioning of those embryos has confirmed this dorsal
localization (data not shown). At late tadpole stages,
NTPDase3 is also highly expressed in the forebrain and
trigeminal ganglia (Fig. 6C, vi).
The NTPDase4 gene also displays a very specific expression
domain. From stage 20, strong staining is detected in a region at
the border of the cement gland of the embryo (Fig. 7A, i and ii).
From stage 24, expression can also be detected in the hatching
gland, as shown in Fig. 7A, iii and iv. NTPDase4 is expressed in
only these two tissues until stage 37 (data not shown).
NTPDase5 displays a very specific tissue expression
domain. First expressed in the notochord at stage 30 (Fig.
7B, i), this gene from stage 37 is only and highly expressed in
the pronephros (Fig. 7B, ii).
The NTPDase6 and NTPDase7 genes are more weakly
expressed in the embryo. At stage 41, NTPDase6 expression is
detected mainly in the head of the embryo, in the forebrain, in the
cement gland, and in the branchial arches (Fig. 7C, i and ii). The
staining in the notochord is also found with the sense probe (Fig.
7C, i) and therefore considered nonspecific. The NTPDase7
gene displays no obvious expression domain. This gene appears
to be expressed ubiquitously at a low level throughout the
embryo (Fig. 7D, i), with slightly stronger expression in the
sensory organs including eyes and otic vesicles (Fig. 7D, ii).
RT-PCR was also performed on a series of embryo
dissections (as shown in the cartoons) to confirm the
expression pattern of these genes (Fig. 8A). Otx-2 as a neural
marker was used to control the quality of the dissection. AsFig. 7. Spatial expression profile of NTPDase4, 5, 6 , and 7 during
development. (A) Whole-mount in situ hybridization with an NTPDase4
DIG-labeled antisense RNA probe was performed on embryos from stages 19–
41. At stage 20, staining can be detected in the cement gland (i) and NTPDase4
remains expressed in this tissue at stage 30 (iii) and until stage 37 (data no
shown). As shown in panel ii, expression is restricted to the outer region of the
cement gland. From stage 24 onward and until stage 37, NTPDase4 is
expressed strongly in another tissue, the hatching gland (ii). At stage 30, some
weak staining can be detected in the somites but as shown by a dorsal view in
panel iv, NTPDase4 is expressed mainly in the hatching gland (iv). (B) Whole
mount in situ hybridization with an NTPDase5 DIG-labeled antisense RNA
probe was performed on embryos from stages 19–41. Stained embryos were
photographed before (ii) and after being cleared (i). NTPDase5 is first detected
in the notochord at stage 30 (i). At later stages, staining can be detected in only
a single tissue, the pronephric tubules (ii). (C) Whole-mount in situ
hybridization with an NTPDase6 DIG-labeled antisense RNA probe was
performed on embryos from stages 19–41. Stained embryos were photo
graphed after being cleared. NTPDase6 expression can be detected only a
stage 41 (i), in the forebrain, cement gland, and branchial arches (ii). (D
Whole-mount in situ hybridization with an NTPDase7 DIG-labeled antisense
RNA probe was performed on embryos from stages 19–41. Stained embryos
were photographed after being cleared. NTPDase7 is weakly expressed during
X. laevis development (i). Its expression is detected mostly in the head of the
embryo, in the sensory organs, and in the branchial arches (ii). All embryos
were analyzed from the same experimental set. The differences in colors resul
from clearing the embryos and photographing them against a white background
to visualize staining. ba, branchial arches; cg, cement gland; e, eye; hg
hatching gland; n, notochord; ov, otic vesicle; p, pronephros.t
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Fig. 8. Embryonic spatial expression profile of NTPDase family. (A) RT-PCR analysis showing the spatial expression of the NTPDase genes during X. laevis
development. As observed previously, each NTPDase gene is expressed in the nervous system of the embryo. However, the NTPDase genes display different spatial
expression. NTPDase2, NTPDase4, NTPDase6, and NTPDase7 seem to be expressed ubiquitously in the embryo, whereas the expression of NTPDase1 and 3 is
almost restricted in the dorsal region of the embryo. Dissections were performed as shown in the diagram. The presumptive nervous system was dissected from the
rest of the embryo at stages 9 and 14. From stage 20, the dorsal region of the embryo was separated from the ventral region of the embryo. At stage 42, the brain and
spinal cord were isolated. Otx-2 was used to check the quality of the dissections. cDNAs were not equalized in order to establish a relative expression level between
components. W.E., whole embryo; A.c., animal cap; Eq., equatorial region; En., endoderm; N.P., neural plate; D., dorsal; V., ventral; N.S., nervous system. (B) RT-
PCR analysis showing the spatial expression of NTPDase genes in dissected stage 37 embryo. Each NTPDase gene except NTPDase5 is expressed in the nervous
tissues. NTPDase3 shows the highest level of expression in the spinal cord, whereas the other genes are more expressed in the brain. Otx-2 and Hoxb9 were used to
control the quality of the dissections, marking anterior and posterior neural tissues, respectively.
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genes are expressed in the dorsal region of the embryo from
stage 20 to stage 38. The expression pattern for NTPDase5 was
not analyzed in this experiment, since it is not expressed before
stage 33 (Fig. 4). At stage 42, the six genes are expressed in the
dorsal region of the embryo, containing the central and
peripheral nervous system. However, they display differentexpression patterns and could be grouped into two groups.
NTPDase2, NTPDase4, NTPDase6 , and NTPDase7 are
ubiquitously expressed in all dissected parts of the embryo.
NTPDase1 and 3 display a more specific expression pattern.
From stage 14 to stage 24, they are expressed only in the dorsal
region of the embryo. Subsequently, their expressions become
more widespread from late tailbud stages.
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in the nervous system during Xenopus development, especially
at stage 37 when physiological measurements have been made
[10]. Therefore, a fine dissection of stage 37 embryos was
performed, pure brain and spinal cord tissues were isolated, and
the expression of NTPDase genes in these tissues was analyzed
by RT-PCR (Fig. 8B). As expected, all the NTPDase genes are
expressed in these tissues except for NTPDase5, which is
expressed only in the nonneuronal tissues of the embryo.
NTPDase2, 4, 6, and 7 are more expressed in the brain,
whereas NTPDase1 seems to be expressed at the same level in
the brain and spinal cord. Only NTPDase3 expression is higher
in the spinal cord than in brain. As previously, Otx-2 was used
to control the quality of the dissection. Hoxb9 expression, as a
posterior spinal cord marker, was also analyzed.
Discussion
This paper reports the cloning of the X. laevis and X.
tropicalis NTPDase family and the analysis of the expression
pattern of this family in X. laevis during development and in
the adult frog. In the human, Chadwick and Frischauf
published a similar study with the cloning of human
NTPDase3, 5, and 6 genes and the analysis of expression of
NTPDase1, 2, 3, 5, and 6 genes in the adult [14]. However, no
analysis of their expression during development was presented.
Therefore, our work is the first to document and compare the
expression pattern of nine members of this family in a
vertebrate adult. It is also the only complete work describing
the temporal and spatial expression pattern of these genes
during the development of a vertebrate.
The structural features of NTPDase genes are highly
conserved in vertebrates
Our data show that X. laevis and tropicalis NTPDase proteins
are highly related to each other and their mammalian homo-
logues. Many of the features described in mammalian proteins
are present in the frog NTPDases. First of all, the five highly
conserved domains are present and the core regions of these
domains are almost completely conserved in all the sequences
analyzed. Studies in mammals have shown the importance of
several residues for the enzymatic activity and/or substrate
specificity [33–35]. These amino acids, such as, for example,
Trp179 (corresponding to human NTPDase3 Trp187), Trp447
(corresponding to human NTPDase3 Trp459), Glu174 (cor-
responding to human NTPDase1 Glu174), and Ser217 (cor-
responding to human NTPDase1 Ser218), are all conserved in
Xenopus (numbering on X. laevis NTPDase1). Furthermore, the
ACR1 and 4 domains of these Xenopus proteins possess
respectively the consensus sequence of the ATPh-phosphate 1-
binding motif [(I/L/V)X(I/L/V/C)DXG(T/S/G) (T/S/G)XX(R/K/
C)] and the consensus sequence of the phosphate 2-binding motif
DXG, found in all mammal NTPDases. Second, the Xenopus
proteins display the same predicted membrane topology:
NTPDases 1, 2, and 3, NTPDase4, and NTPDase7 possess a
large extracellular domain (containing the ACR domains) flankedby a small cytoplasmic tail in both the N- and the C-termini of
the protein. Only one transmembrane domain could be identified
in NTPDases 5 and 6 at the N-terminus domain of these proteins.
Third, these NTPDases have been shown to be highly
glycosylated and glycosylation is essential for their enzymatic
activity [36]. Several putative N-glycosylation sites can be
identified along the sequences of these Xenopus proteins,
suggesting an important role for N-glycosylation in the function
of these proteins as has been documented for their mammalian
homologues [37]. Furthermore, as in mammals, Asn73 (num-
bering on X. laevis NTPDase1) is conserved in all the sequences
analyzed, except NTPDases 5 and 6. This residue has been
shown to be essential for full activity of human NTPDase3 [38].
Other residues, such as 11 glycine residues, are conserved in all
Xenopus sequences, and 9 of the glycine residues have been
shown by mutagenesis in mammals to be essential for the
activity of these proteins [39]. The Xenopus proteins therefore
possess all the characteristics of the mammal NTPDases,
suggesting that it is likely their enzymatic activity will be
similar to that of their mammalian homologue. The biochemical
characterization of these proteins is currently in progress in our
laboratory.
Despite the high degree of conservation among all these
proteins in the frog species, our analysis shows that each
member is more related to its homologue than to the other
members of the family in the same species. This is particularly
obvious in the N- and C-terminal regions of the proteins. These
regions possess the putative transmembrane domains, which
have been shown to be involved in the substrate specificity and
total activity of the enzymes [40]. The location and the number
of the transmembrane domains of each enzyme are conserved
between the two frog species, highlighting the importance of
these domains. Mammalian NTPDase1, 2, 3, and 8 proteins are
very related to one another but their substrate specificities
differ. It has been suggested that the specification of the
substrate can be due to the cysteine-rich region between ACR 4
and 5, whose cysteine could be involved in the tertiary
structure of these proteins [41]. As in mammals, this region
is the least conserved among all the sequences analyzed here.
However, seven cysteines are conserved among NTPDases 1,
2, and 3, especially Cys411 (numbering on X. laevis
NTPDase1), corresponding to human Cys399, which has been
shown to be involved in the correct processing of the protein to
the plasma membrane [42].
Members of the NTPDase family have distinct patterns of
temporal and spatial expression
Our evolutionary analysis shows that, as in mammals, the
NTPDases inXenopus could be grouped into three groups, based
on their sequence analysis but also on their expression patterns.
The first group consists of NTPDases 1, 2, 3, and 8. We show
also that with the exception of NTPDase8, their temporal
expression patterns are similar, showing an increase in zygotic
expression between stages 15 and 19. The second group
comprises NTPDase4 and NTPDase7, which are expressed
maternally during X. laevis development and are expressed in all
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NTPDases 5 and 6, whose sequences are highly identical.
However, their expression patterns during development and in
the adult frog differ. NTPDase5 displays an expression pattern
that is more tissue and time specific than that of NTPDase6. Both
of these genes are more related to the invertebrate and plant
NTPDases [14]; therefore, they could be derived from the more
ancestral genes of the family.
The NTPDase proteins display a wide expression pattern in
Xenopus, similar to that described in mammals. In the adult
frog, all tissues tested express at least one member of this
family. Each member of the family, except NTPDase5, can be
detected in the brain and spinal cord of the adult frog and late
tadpole stages. The strong presence of NTPDases 1, 2, 3, and
8 reflects the importance of the purine signaling in the different
functions of the nervous system.
NTPDase4, NTPDase4a, NTPDase6, and NTPDase7 are
expressed in almost all the tissues tested as described in mouse
[20,21] or in human [14]. However, the expression profile of
NTPDase8 is different between the adult frog and mammals.
NTPDase8 is expressed in a few tissues in mouse, human, and
rat ([15] and EST analysis on NCBI website), whereas in X.
laevis, its expression can be detected in almost all tissues
tested. NTPDase5 is highly expressed in the frog mesonephros
and in human and mouse (EST analysis); its expression is also
the highest in the metanephros [14]. As in human and mouse,
NTPDase3 is expressed mostly in the nervous system ([14],
EST analysis on NCBI website).
NTPDases may have specific roles in X. laevis
We have shown that except for NTPDase8, all NTPDase
genes are expressed during X. laevis development. The
zygotic expression of NTPDases 1, 2, 3, 4, and 6 is up-
regulated between stages 15 and 19, suggesting a possible
role for these genes during neurulation. Only NTPDase5
expression is switched on at later stages and its expression is
detected only in the pronephros at stage 34, the time at which
the pronephros becomes functional as an excretory organ.
With the high level of expression of this gene in the adult
vertebrate, it seems that this protein is involved in the
maturation or function of the kidney. NTPDase7 expression is
constant during development, ruling out a role for this protein
during a specific stage of embryogenesis. Interestingly, we
could not amplify NTPDase8 at any embryonic stage. In
mammals, its expression has been studied only in adult [15],
but the expression profile suggested by analysis of EST
counts on the NCBI Internet website shows that NTPDase8 is
not expressed in mouse, rat, and human embryos and is thus
consistent with our results.
In situ hybridization analysis showed clearly that these
genes are expressed specifically in different organs during
early development. NTPDase1 is strongly expressed in the
blood compartments and notochord, NTPDase2 in the
developing somites, NTPDase5 in the pronephros, and
NTPDase4 in the cement and hatching glands. Our data
therefore suggest that NTPDase proteins may play specificroles during development in X. laevis. Since there is such a
high degree of conservation of this family between frog and
mammals, it is highly probable that their functions will also
be similar. With the development of overexpression, morpho-
lino knock-down, and transgenesis technologies, Xenopus
species provide a very powerful model to study the roles of
these proteins in the early development of a vertebrate. These
studies are now in progress in our laboratory.
Materials and methods
Bioinformatics
X. laevis EST clones were identified by a TBLASTN (Basic Local
Alignment Search Tool) search on the NCBI EST_others database using the
homologous human protein sequence [43]. The identified clones were ordered
from the UK MRC HGMP Resource Centre, Cambridge (cf. Table 1). X.
tropicalis sequences were identified by the same procedure and by a
TBLASTN search performed on the X. tropicalis EST or genome database of
the Joint Genome Institute (JGI) website. The accession numbers of the clones
carrying these sequences are given in Table 1.
Alignments were performed using the program ALIGNp [44] or ClustalW
[45]. Conceptual translation of cDNA and analysis of the protein sequence were
performed on the Infobiogen Internet site using the programs MWCALC, TM-
Base [46], and ScanProsite [47]. A phylogenetic tree was built using the
program AliBee [48] on the Genebee Internet site.
DNA sequencing
The clones were sequenced in-house from both strands using the BigDye
Terminator Cycle Sequencing Ready Reaction Kit (Perkin–Elmer) according to
the manufacturer’s protocol.
Embryo culture and dissection
Embryos were obtained by in vitro fertilization of eggs collected in Barth X
saline from a hormonally stimulated X. laevis female by adding crushed testis
isolated from a sacrificed male. Fertilized eggs were dejellied in 2% cysteine
hydrochloride, pH 8 (BDH Laboratory Supplies), and washed several times
with 1/10 Barth X. Embryos were then cultured to the required stage in 1/10
Barth X in the presence of 10 ng/ml of gentamycin sulfate. The embryos were
staged according to Nieuwkoop and Faber [49]. Dissections of anesthetized
embryos were performed in Barth X using forceps and an eyebrow hair knife.
For the fine dissection of the nervous system, fifty stage 37 embryos were
anesthetized in MS222 and with the aid of fine tungsten pins, the brain and
spinal cord carefully were dissected free from the embryo.
RT-PCR
Total RNA from whole or dissected embryos was isolated as described by
Barnett and colleagues [50]. Total RNA from adult tissues was extracted using
Trizol (Invitrogen) following the manufacturer’s protocol. cDNA synthesis and
RT-PCR were performed as described by Barnett and colleagues [50] but
without any radioactive nucleotides. For each gene, specific primers were
designed outside of the apyrase conserved regions, based on the X. laevis
sequences, except for the primers for NTPDase5 and 8, which were designed
on the X. tropicalis sequence of these genes.
The following NTDase4 primers amplify both transcripts:
NTPDase1, U: GCAACAATGGCCGAGGA; D: GGCGGAAGTGCAAG-
GAA;
NTPDase2, U: AGCGGTACTGCAAGTCC; D: CAGAGCTCCACC-
TACTG;
NTPDase3 , U: GGTAAGCCAGGCTCTGA; D: CTGGCAAG-
GACTCCTCT;
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GAAC;
NTPDase5, U: GTCAGCATCATAAATGG; D: ATTTCAGTC-
CAAGTCCC;
NTPDase6 , U: AGCGGAGCACCGAATCT; D: GATGCCCA-
TAACTTCTG;
NTPDase7, U: GACCAGGACCTCCATGT; D: GTTGTCCAGGCCAT-
GCT;
NTPDase8, U: CTACACCCACAGCTACCTCT; D: GTCCCCTCCACG-
GTCACATT.
To discriminate between the NTPDase4 and NTPDase4a genes, primers
were chosen on each side of the predictive alternative splicing site (Fig. 3B):
U: CACAGCAGGCATTCTAGACA; D: CACAGCCAAGATT-
GAACTCC.
After optimization of the PCR conditions by using a gradient PCR machine
(Eppendorf), PCR products were cloned into pGEMT-easy (Promega) and verified
by sequencing. The optimized conditions are n cycles of 94-C for 1 min, x for 1
min, and 72-C for 1 min, where n and x are respectively: 30 cycles and 59-C for
NTPDase1, 26 cycles and 59-C for NTPDase2, 28 cycles and 59-C for NTPD-
ase3, 26 cycles and 57-C for NTPDase4, 27 cycles and 55-C for NTPDase4/4a,
31 cycles and 50-C for NTPDase5, 30 cycles and 57-C for NTPDase6, 26 cycles
and 59-C for NTPDase7, and 30 cycles and 57-C for NTPDase8. All PCR
included an initial denaturation for 3 min at 94-C and a final extension for 5 min at
72-C.
Otx-2, an anterior neural marker [51], and Hoxb9, a posterior neural marker
(spinal cord) [52], were used to control the quality of the dissections and their
amplifications were performed as described in [53]. For each experiment, the
quantity of input cDNA was determined by equalization of the ODC or EF1a
signal since these genes have been considered to be expressed at the same level
during development and in the different adult tissues, respectively [54,55].
Linearity of signal was controlled by carrying out PCRs on doubling dilutions
of cDNA, illustrated by the triangle in Figs. 4 and 5. Negative controls (RNA,
RT, and cDNA) were also performed.
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as described by Harland
[56] with several modifications. Pigmented embryos were fixed in MEMFA (0.5
M MOPS, pH 7.4, 100 mM EGTA, 1 mM MgSO4, 4% formaldehyde), washed
in water, dehydrated in ethanol, and stored at 20-C. They were hybridized with
either antisense or sense 3V-UTR-specific RNA probes for each gene of the
NTPDase family. Each probe was made using a DIG RNA labeling kit (Roche)
and the original DNA template was removed after incubation with DNAse I at
37-C for 20 min.
1.3 kb of NTPDase1 3V-UTR was subcloned into pBSKS, and the antisense
and sense strands were transcribed with T7 RNA polymerase after linearization of
two different clones by KpnI. 0.5 kb of NTPDase2 3V-UTR was amplified by
PCR and cloned into pGEMT-easy; the antisense strand was transcribed with T7
RNA polymerase and the sense strand with Sp6 RNA polymerase from this
plasmid linearized respectively by PstI and NcoI. 0.7 kb of NTPDase3 3V-UTR
was cloned into pBSKS; the antisense strand was transcribed with T3 RNA
polymerase and the sense strand with T7 RNA polymerase from this plasmid
linearized respectively by EcoRI and HindIII. 1.4 kb of NTPDase4 3V-UTR was
cloned into pBSKS and the antisense strand was transcribed with T3 RNA
polymerase and the sense strand with T7 RNA polymerase from this plasmid
linearized respectively by SacI and BamHI. 0.5 kb of NTPDase5 3V-UTR was
amplified by PCR and cloned into pGEMT-easy; the antisense and sense strands
were transcribed with T7 RNA polymerase after linearization of two different
clones by SacI. 0.7 kb of NTPDase6 was subcloned into pBSKS, and the
antisense strand was transcribed with T7 RNA polymerase and the sense strand
with T3 RNA polymerase from this plasmid linearized respectively by BamHI
and SacI. One kilobase of the NTPDase7 3V-UTR (IMAGE clone BG363994)
was subcloned into pBSKS and the antisense strand was transcribed with T7RNA polymerase and the sense strand with T3 RNA polymerase from this
plasmid linearized respectively by HindIII and NotI. Hybridization was visualized
using sheep anti-DIG-alkaline phosphatase antibody (Boehringer), previously
pre-absorbed on control embryos, and BM Purple AP substrate (Roche). Embryos
were photographed before and after being cleared in Murray’s solution (benzyl
benzoate:benzyl alcohol 2:1).
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